1. Home
  2. ABOS vs PDEX Comparison

ABOS vs PDEX Comparison

Compare ABOS & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • PDEX
  • Stock Information
  • Founded
  • ABOS 1996
  • PDEX 1978
  • Country
  • ABOS United States
  • PDEX United States
  • Employees
  • ABOS N/A
  • PDEX N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • PDEX Medical/Dental Instruments
  • Sector
  • ABOS Health Care
  • PDEX Health Care
  • Exchange
  • ABOS Nasdaq
  • PDEX Nasdaq
  • Market Cap
  • ABOS 109.6M
  • PDEX 105.5M
  • IPO Year
  • ABOS 2021
  • PDEX N/A
  • Fundamental
  • Price
  • ABOS $1.55
  • PDEX $30.27
  • Analyst Decision
  • ABOS Strong Buy
  • PDEX Strong Buy
  • Analyst Count
  • ABOS 3
  • PDEX 1
  • Target Price
  • ABOS $8.00
  • PDEX $56.00
  • AVG Volume (30 Days)
  • ABOS 275.1K
  • PDEX 48.2K
  • Earning Date
  • ABOS 11-12-2025
  • PDEX 10-30-2025
  • Dividend Yield
  • ABOS N/A
  • PDEX N/A
  • EPS Growth
  • ABOS N/A
  • PDEX 122.94
  • EPS
  • ABOS N/A
  • PDEX 3.31
  • Revenue
  • ABOS N/A
  • PDEX $70,231,000.00
  • Revenue This Year
  • ABOS N/A
  • PDEX $7.22
  • Revenue Next Year
  • ABOS N/A
  • PDEX N/A
  • P/E Ratio
  • ABOS N/A
  • PDEX $9.68
  • Revenue Growth
  • ABOS N/A
  • PDEX 23.65
  • 52 Week Low
  • ABOS $0.86
  • PDEX $23.47
  • 52 Week High
  • ABOS $2.66
  • PDEX $70.26
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 35.12
  • PDEX 45.69
  • Support Level
  • ABOS $1.74
  • PDEX $31.00
  • Resistance Level
  • ABOS $2.04
  • PDEX $33.30
  • Average True Range (ATR)
  • ABOS 0.16
  • PDEX 2.10
  • MACD
  • ABOS -0.07
  • PDEX 0.11
  • Stochastic Oscillator
  • ABOS 9.20
  • PDEX 22.65

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

Share on Social Networks: